1-46512214-G-C
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_172225.2(DMBX1):āc.854G>Cā(p.Gly285Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00216 in 1,614,044 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G285C) has been classified as Uncertain significance.
Frequency
Consequence
NM_172225.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DMBX1 | NM_172225.2 | c.854G>C | p.Gly285Ala | missense_variant | 6/6 | ENST00000360032.4 | |
DMBX1 | NM_001387776.1 | c.869G>C | p.Gly290Ala | missense_variant | 5/5 | ||
DMBX1 | NM_147192.4 | c.869G>C | p.Gly290Ala | missense_variant | 6/6 | ||
DMBX1 | NM_001387775.1 | c.854G>C | p.Gly285Ala | missense_variant | 5/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DMBX1 | ENST00000360032.4 | c.854G>C | p.Gly285Ala | missense_variant | 6/6 | 1 | NM_172225.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00156 AC: 238AN: 152130Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00159 AC: 398AN: 250798Hom.: 3 AF XY: 0.00147 AC XY: 200AN XY: 135716
GnomAD4 exome AF: 0.00222 AC: 3250AN: 1461796Hom.: 7 Cov.: 31 AF XY: 0.00219 AC XY: 1589AN XY: 727220
GnomAD4 genome AF: 0.00156 AC: 238AN: 152248Hom.: 0 Cov.: 32 AF XY: 0.00145 AC XY: 108AN XY: 74440
ClinVar
Submissions by phenotype
DMBX1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 16, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at